Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54913. The disease onset before age 18 is generally regarded as early-onset (EOS) when the patients confer more familial vulnerability and poor outcomes [1] . The neurodevelopmental hypothesis posits that the onset of SZ is associated with early development of the nervous system [2] . We paid attention to this period and speculate that the altered gene expression in these patients may be associated with the disease process.
Peripheral blood mononuclear cells (PBMCs) have represented an accessible tissue source for gene expression, as it is easily collected from patients. There already have many gene expression profiling studies using PBMCs, a consistent conclusion about the expression alteration of schizophrenia is lacked [3, 4] .
Experimental design, materials and methods
We recently collected blood samples from 18 EOS cases and 12 controls. Then we generated whole-genome gene expression profiles on PBMCs from these samples by using microarray. 17,200 valid probes detected in our experiment were used to identify altered gene expressions.
Study population
A total of 18 first-onset SZ patients (8 males and 10 females, aged 14.78 ± 1.70 years) were included in our study. They were untreated and drug-naïve patients diagnosed by at least two experienced psychiatrists independently according to the Diagnosis and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria for SZ. 12 healthy controls (6 males and 6 females, aged 14.75 ± 2.14 years) were recruited into the study. Teenagers with a history of other mental health or neurological diseases were enrolled into our study. All participants 
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Genomics Data j o u r n a l h o m e p a g e : h t t p : / / w w w . j o u r n a l s . e l s e v i e r . c o m / g e n o m i c s -d a t a / were unrelated Han Chinese recruited from the north of China. And both the participants and their parents signed the informed consent before participation. The study was approved by Medical Research Ethics Committee of Shanxi Medical University.
Microarray and quality control
Peripheral blood was collected. NanoDrop ND-1000 was used to quantify total RNA after RNA extraction, and RNA integrity was assessed by standard denaturing agarose gel electrophoresis. Agilent Array platform was employed to perform the microarray analysis. Following RNA amplification, hybridization and image scanning, signal intensities were normalized in the quantile method using GeneSpring GX v11.5.1 (Agilent Technologies), and low intensity mRNAs were filtered (mRNAs that at least 20 out of 30 samples have flags in Present or Marginal were chosen for further analysis). R [5] was used to perform the data processing and analyses of mRNA data. The sample preparation and microarray hybridization were performed based upon the manufacturer's standard protocols with minor modifications.
Log2-ration was used by quantile normalization. The distributions of the intensities after normalized among all samples were shown in Fig. 1 , Identification of differentially expressed genes between SZ cases and controls was made using R package genefilter [6] .We identified 84 differentially expressed genes through fold change and P value filtering (FC ≥ 2 and P adjusted b 0.05) listed in Table 1 .
Discussion
All the participants in our study were teenagers with similar age (b18 years), and their brains were still developing. The SZ cases were neither under medication nor had a history of pharmacotherapy. We mainly described a dataset about gene expression profiles of the 30 samples measured by Arraystar.
Among the 84 DE genes listed above, SLC18A1 has been reported to be associated with SZ [7, 8] . In addition, CTLA4 was also identified showing a high expression level in SZ [9] which is consistent with the results from our study. Through our description above, we believe that this dataset will be useful for the exploration of SZ's pathogenesis in the future. C11orf49  SLC18A1  NAT1  MYBPC1  KIF23  GTF2H1  ALDH4A1  IL28RA  ERVFRDE1  ALDH3A1  ODF4  TSPAN16  CCNE1  TGFA  SATB2  SLC45A1  IL1RL2  BBS5  CTLA4  EPPIN  OSGIN1   NKAIN4  EYA2  OPRL1  C21orf56  SLC5A4  GJB5  CCDC134  MYL3  SCAP  PRICKLE2  ENTPD3  RNF186  EIF4G1  UGT2B4  RASSF6  FGA  PAICS  SH3RF2  UBD  ECM1  HOXD11   LCE2D  UBAP2L  RFPL4B  CCL26  DARC  POU6F2  PNMA2  CNGB3  DEFB135  FAM110B  MAL2  SARDH  NUP188  C9orf171  TMEM27  XAGE3  CUL4B  PNCK  SMIM9  ERAS   GAGE10  ATP2B3  TKTL1  USP9Y  LDB1  ACP2  P4HA3  C11orf1  FAM19A2  C12orf68  HCFC2  RPL10L  PRKAB2  CA12  C15orf2  ZP2  SALL1  C16orf46  SLC5A2  GPT2 Down-regulated genes
IQCF6 POM121L12
(p b 0.05 with a fold change N2). Fig. 1 . Quality assessment of mRNA data after filtering. The box-plot shows the distribution of normalized signal intensity by array; the distributions of log2-ratios among all samples are nearly the same after normalization.
